Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-15T19:19:35.271Z Has data issue: false hasContentIssue false
  • English
  • Français

Transcatheter closure of elongated and pulmonary hypertensive patent arterial duct in infants using Amplatzer vascular plug II

Published online by Cambridge University Press:  30 January 2020

Sneha M. Jain Open the ORCID record for Sneha M. Jain [Opens in a new window] ,
Priya M. Pradhan ,
Supratim Sen  and
Bharat V. Dalvi
Sneha M. Jain
Affiliation:
Department of Cardiology, SRCC Children’s Hospital, Mumbai, India
Priya M. Pradhan
Affiliation:
Department of Cardiology, SRCC Children’s Hospital, Mumbai, India
Supratim Sen
Affiliation:
Department of Cardiology, SRCC Children’s Hospital, Mumbai, India
Bharat V. Dalvi*
Affiliation:
Department of Cardiology, SRCC Children’s Hospital, Mumbai, India Glenmark Cardiac Centre, Mumbai, India
*
Address for Correspondence: B. V. Dalvi, MD, DM, Glenmark Cardiac Centre, 101/102 Swami Krupa Coop Hsg Scty, D L Vaidya Road, Dadar (W), Mumbai400028, India. Tel: +91 22 24335055; Fax: +91 22 24335058; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To evaluate the feasibility, efficacy, and safety of Amplatzer vascular plug II in large and elongated ducts in infants.

Introduction:

Patent arterial duct device closure is technically challenging in infants with large and elongated ducts because Amplatzer duct occluder and Amplatzer duct occluder II have high chances of causing aortic coarctation and left pulmonary artery stenosis, respectively. The Amplatzer vascular plug II being soft with no retention discs on either sides helps in mitigating these problems.

Method:

This is a prospective, observational study involving infants with clinical, echocardiographic and angiographic evidence of large left to right shunt. All the children underwent duct closure using Amplatzer vascular plug II.

Results:

Eighteen infants qualified for the study. Mean age and weight were 8.63 ± 3.84 months and 6.3 ± 1.7 kg, respectively. The angiographic mean duct diameter at the pulmonary artery end was 4.66 ± 0.92 mm, and the mean duct length was 9.4 ± 2.48 mm. The size of Amplatzer vascular plug II used varied from 6 mm to 10 mm. Technical success was achieved in 16/18 cases. One patient had device embolisation, and in the other, the device was found to be unstable. The ratio of Amplatzer vascular plug II size to the duct diameter was 1.65 ± 0.27, while the ratio of ductal length to device length was 1.48 ± 0.46 in those with successful outcome.

Conclusions:

Amplatzer vascular plug II is a safe and effective option in appropriately selected infants with elongated ducts. Diameter and length of Amplatzer vascular plug II vis-a-vis those of the ductus are important determinants of the successful outcome.

Keywords

Device closureCHDleft to right shunts
Type
Original Article
Information
Cardiology in the Young , Volume 30 , Issue 2 , February 2020 , pp. 243 - 248
Copyright
© Cambridge University Press 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Backes, CH, Rivera, BK, Bridge, JA, et al. Percutaneous Patent Ductus Arteriosus (PDA) closure during infancy: a meta-analysis. Pediatrics 2017; 139: e20162927CrossRefGoogle ScholarPubMed
El-Said, HG, Bratincsak, A, Foerster, SR, et al. Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc Cardiovasc Cerebrovasc Dis 2013; 2: e000424.Google ScholarPubMed
Schwartz, M, Glatz, AC, Rome, JJ, Gillespie, MJ. The Amplatzer vascular plug and Amplatzer vascular plug II for vascular occlusion procedures in 50 patients with congenital cardiovascular disease. Catheter Cardiovasc Interv 2010; 76: 411–417.CrossRefGoogle ScholarPubMed
Jang, GY, Son, CS, Lee, JW, Lee, JY, Kim, SJ. Complications after transcatheter closure of patent ductus arteriosus. J Korean Med Sci 2007; 22: 484–490.CrossRefGoogle ScholarPubMed
Baspinar, O, Irdem, A, Sivasli, E, et al. Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg. Pediatr Cardiol 2013; 34: 88–94.10.1007/s00246-012-0393-6CrossRefGoogle ScholarPubMed
Masura, J, Tittel, P, Gavora, P, Podnar, T. Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J 2006; 151: 755.e7–755.e10.10.1016/j.ahj.2005.12.010CrossRefGoogle ScholarPubMed
Duke, C, Chan, KC. Aortic obstruction caused by device occlusion of patent arterial duct. Heart 1999; 82: 109–111.CrossRefGoogle ScholarPubMed
Pass, RH, Hijazi, ZM, Hsu, DT, Lewis, V, Hellenbrand, WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial. Initial and one-year results. J Am Coll Cardiol 2004; 44: 513–519.CrossRefGoogle ScholarPubMed
Sen, S, Jain, S, Dalvi, B. Embolization of ceramic coated PDA devices into the descending thoracic aorta: probable mechanisms and retrieval strategies. Cardiol Young 2019; 29: 842–844.10.1017/S104795111900091XCrossRefGoogle Scholar
Pepeta, L, Dippenaar, A. Ductal closure using the Amplatzer duct occluder type two: experience in Port Elizabeth hospital complex, South Africa: cardiovascular topic. Cardiovasc J Afr 2013; 24: 202–207.CrossRefGoogle ScholarPubMed
Thanopoulos, B, Eleftherakis, N, Tzannos, K, Stefanadis, C. Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children. Am Heart J 2008; 156: 917.e1–917.e6.10.1016/j.ahj.2008.08.001CrossRefGoogle ScholarPubMed
Sant’Anna, LOC, da Costa, RN, Ribeiro, MS, et al. Percutaneous occlusion of patent ductus arteriosus with the Amplatzer® vascular plug II device: early experience in three reference centers. Rev Bras de Cardiol Invasiva 2012; 20: 191–198.Google Scholar
Delaney, JW, Fletcher, SE. Patent ductus arteriosus closure using the Amplatzer® vascular plug II for all anatomic variants. Catheter Cardiovasc Interv 2013; 81: 820–824.CrossRefGoogle ScholarPubMed
Garay, FJ, Aguirre, D, Cardenas, L, Springmuller, D, Heusser, F. Use of the Amplatzer vascular plug II device to occlude different types of patent ductus arteriosus in pediatric patients. J Int Cardiol 2015; 28: 198–204.10.1111/joic.12188CrossRefGoogle ScholarPubMed
VanLoozen, D, Sandoval, JP, Delaney, JW, et al. Use of Amplatzer vascular plugs and Amplatzer duct occluder II additional sizes for occlusion of patent ductus arteriosus: a multiinstitutional study. Cathet Cardiovasc Intervent 2018; 92: 1323–1328.CrossRefGoogle Scholar
Krichenko, A, Benson, LN, Burrows, P, Moes, CAF, McLaughlin, P, Freedom, RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989; 63: 877–880.10.1016/0002-9149(89)90064-7CrossRefGoogle ScholarPubMed
Barwad, P, Ramakrishnan, S, Kothari, SS, et al. Amplatzer vascular plugs in congenital cardiovascular malformations. Ann Pediatr Cardiol 2013; 6: 132–140.Google ScholarPubMed